Efficacy and safety of nebulized glycopyrrolate (EP‐101) in COPD

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|79|3|492-500

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.79, Iss.3, 2015-03, pp. : 492-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double‐blinded, placebo‐controlled, split‐face study

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 2, 2015-02 ,pp. : 278-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of aclidinium bromide in patients with COPD: A phase 3 randomized clinical trial in a Korean population

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1222-1228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI*

By Sutherland E. Rand   Brazinsky Shari   Feldman Gregory   McGinty Joe   Tomlinson LaTanya   Denis-Mize Kimberly  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 653-661

Informa Healthcare

Access to resources Recommend Favorite

Flecainide: Safety and Efficacy

By  

Cardiology, Vol. 111, Iss. 2, 2008-03 ,pp. : 82-82

Karger

Access to resources Recommend Favorite

Efficacy of Nebulized Flunisolide Combined with Salbutamol and Ipratropium Bromide in Stable Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 73, Iss. 5, 2006-09 ,pp. : 603-609

Karger

Access to resources Recommend Favorite